Bristol-Myers Squibb Company (0R1F.IL)
IOB - IOB Delayed price. Currency in USD
Add to watchlist
At close: 07:14PM BST
| Previous close | 49.18 |
| Open | 0.00 |
| Bid | 46.17 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 180,957 |
| Market cap | 104.488B |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | 13.10 |
| EPS (TTM) | 3.71 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 2.28 (4.04%) |
| Ex-dividend date | 05 Oct 2023 |
| 1y target est | N/A |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksNeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NeoGenomics (NEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.